AIDEVI product is an NMN health product developed by Tinus Pharma Inc. in the United States. Its NMN purity is as high as 99.8%, and each particle contains 300mg of NMN, making it one of the highest concentrations of NMN products on the market. The AIDEVI product also adopts the Nobel Prize winning nanoliposome technology, which can improve the absorption and bioavailability of NMN, allowing it to enter cells within 30 minutes after consumption and quickly convert into NAD+
